Bisphosphonates for the prevention of bone metastases

被引:15
作者
Coleman, RE [1 ]
机构
[1] Weston Pk Hosp, YCR Acad Unit Clin Oncol, Canc Res Ctr, Sheffield S10 2SJ, S Yorkshire, England
关键词
D O I
10.1053/sonc.2002.37415
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:43 / 49
页数:7
相关论文
共 48 条
[1]  
Alvarez Enrique, 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P316
[2]   In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates [J].
Aparicio, A ;
Gardner, A ;
Tu, Y ;
Savage, A ;
Berenson, J ;
Lichtenstein, A .
LEUKEMIA, 1998, 12 (02) :220-229
[3]   Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro [J].
Benford, HL ;
McGowan, NWA ;
Helfrich, MH ;
Nuttall, ME ;
Rogers, MJ .
BONE, 2001, 28 (05) :465-473
[4]   Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, M ;
Blacklock, H ;
Bell, R ;
Simeone, JF ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :593-602
[5]  
Boissier S, 2000, CANCER RES, V60, P2949
[6]  
Boissier S, 1997, CANCER RES, V57, P3890
[7]  
Corey E, 2001, J BONE MINER RES, V16, pS192
[8]  
Croucher P, 2002, BONE, V30, p39S
[9]   Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma [J].
Cruz, JC ;
Alsina, M ;
Craig, F ;
Yoneda, T ;
Anderson, JL ;
Dallas, M ;
Roodman, GD .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (04) :441-447
[10]   Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment [J].
Derenne, S ;
Amiot, M ;
Barillé, S ;
Collette, M ;
Robillard, N ;
Berthaud, P ;
Harousseau, JL ;
Bataille, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (12) :2048-2056